Evidence map›Paper›PMID 29895585›Full record

ArticleJournal of the American Heart Association2018

Metformin Improves Neurologic Outcome Via AMP-Activated Protein Kinase-Mediated Autophagy Activation in a Rat Model of Cardiac Arrest and Resuscitation.

Juan Zhu, Kewei Liu, Kaibin Huang, Yong Gu, Yafang Hu, Suyue Pan, Zhong Ji

Open access · goldAbstract read
In one paragraph

Article in Journal of the American Heart Association, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed
4.9field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 65 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Juan ZhuDepartment of Neurology, Nanfang Hospital Southern Medical University, Guangdong, China.
Kewei LiuDepartment of Neurology, Nanfang Hospital Southern Medical University, Guangdong, China.
Kaibin HuangDepartment of Neurology, Nanfang Hospital Southern Medical University, Guangdong, China.
Yong GuDepartment of Neurology, Nanfang Hospital Southern Medical University, Guangdong, China.
Yafang HuDepartment of Neurology, Nanfang Hospital Southern Medical University, Guangdong, China.
Suyue PanDepartment of Neurology, Nanfang Hospital Southern Medical University, Guangdong, China jizhong@fimmu.com pansuyue82@126.com.
Zhong JiDepartment of Neurology, Nanfang Hospital Southern Medical University, Guangdong, China jizhong@fimmu.com pansuyue82@126.com.
Nanfang Hospital · CNSouthern Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSudden cardiac arrest (CA) often results in severe injury to the brain, and neuroprotection after CA has proved to be difficult to achieve. Herein, we sought to investigate the effects of metformin pretreatment on brain injury secondary to CA and cardiopulmonary resuscitation. METHODS AND

resultsRats were subjected to 9-minute asphyxial CA after receiving daily metformin treatment for 2 weeks. Survival rate, neurologic deficit scores, neuronal loss, AMP-activated protein kinase (AMPK), and autophagy activation were assessed at indicated time points within the first 7 days after return of spontaneous circulation. Our results showed that metformin pretreatment elevated the 7-day survival rate from 55% to 85% and significantly reduced neurologic deficit scores. Moreover, metformin ameliorated CA-induced neuronal degeneration and glial activation in the hippocampal CA1 region, which was accompanied by augmented AMPK phosphorylation and autophagy activation in affected neuronal tissue. Inhibition of AMPK or autophagy with pharmacological inhibitors abolished metformin-afforded neuroprotection, and augmented autophagy induction by metformin treatment appeared downstream of AMPK activation.

conclusionsTaken together, our data demonstrate, for the first time, that metformin confers neuroprotection against ischemic brain injury after CA/cardiopulmonary resuscitation by augmenting AMPK-dependent autophagy activation.

Indexed as

AMP-Activated Protein KinasesAnimalsApoptosisAutophagyBrain IschemiaCA1 Region, HippocampalCardiopulmonary ResuscitationDisease Models, AnimalHeart ArrestMaleMetforminNeuronsNeuroprotective AgentsPhosphorylationRats, Sprague-DawleySignal TransductionAMP-Activated Protein KinasesMetforminNeuroprotective AgentsAMP‐activated protein kinase signal transductionautophagycardiac arrestdiabetic therapy/glitazonesmetforminneuroprotection

Identifiers

PMID29895585
PMCPMC6220525
OpenAlexW2808572918

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.